News

Dementia Risk in Patients With Atrial Fibrillation Tied to Diabetes, Stroke

By

Sheila Jacobs

Publish Date May 20, 2022

Researchers sought to assess the risk factors for dementia in older adults with atrial fibrillation.

Serum Urate Levels in Gout and Risk for Parkinson Disease in Older Adults

By

Maria Arini Lopez, PT, DPT

Publish Date May 20, 2022

Researchers sought to assess whether serum urate possesses a neuroprotective effect against the risk for Parkinson disease in patients with gout.

Gabapentin-Involved Overdose Deaths Increased Between 2019 and 2020

By

Diana Ernst, RPh

Publish Date May 20, 2022

Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.

Nonstimulant ADHD Treatment Option Approved for Adults

By

Brian Park, PharmD

Publish Date May 20, 2022

The approval was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.

US Hospitals Facing Shortage of Dye Needed for Life-Saving Scans

Publish Date May 20, 2022

US hospitals are running low on contrast media needed for enhanced X-rays and computed tomography and magnetic resonance imaging scans.

Pollution Accounts for 1 in 6 Deaths Worldwide

Publish Date May 20, 2022

Pollution remains responsible for about 9 million deaths per year, or one in six deaths worldwide.

Prevalence of Past-Month Adolescent Vaping 8.6% Overall

Publish Date May 20, 2022

The prevalence of adolescent vaping is 8.6% in 47 lower-middle, upper-middle, and high-income countries, and the prevalence of frequent vaping is 1.7%.

Clinical Predictors Could Guide Lithium Dosage in Bipolar Disorder

Publish Date May 20, 2022

A model comprising 6 clinical variables could be used to guide lithium dosage.

Dapsone for Alzheimer Disease Exacerbation as a Preventive Therapeutic Option

By

Sheila Jacobs

Publish Date May 19, 2022

Researchers sought to assess the clinical prevalence of Alzheimer disease in patients with leprosy, also known as Hansen’s disease, and inflammasome activity.

Effect of Alemtuzumab on Blood Pressure in Patients With Multiple Sclerosis

By

Sheila Jacobs

Publish Date May 19, 2022

Researchers sought to assess the change in blood pressure in patients with MS treated with ATZ and prior HDMP treatment compared with patients receiving HDMP only for acute relapse.